207 related articles for article (PubMed ID: 25973241)
21. Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease.
Dransfield MT; Kunisaki KM; Strand MJ; Anzueto A; Bhatt SP; Bowler RP; Criner GJ; Curtis JL; Hanania NA; Nath H; Putcha N; Roark SE; Wan ES; Washko GR; Wells JM; Wendt CH; Make BJ;
Am J Respir Crit Care Med; 2017 Feb; 195(3):324-330. PubMed ID: 27556408
[TBL] [Abstract][Full Text] [Related]
22. Negligible effect of vitamin D supplementation on exacerbation in patients with chronic obstructive pulmonary disease: meta-analysis.
Hua Y; Jiang T; Feng J; Zou M
Biochem Med (Zagreb); 2023 Oct; 33(3):030703. PubMed ID: 37841773
[TBL] [Abstract][Full Text] [Related]
23. Expression and significance of serum vitamin D and LL-37 levels in infants with bacterial pneumonia.
Zhao S; He Y; Pan M; Chen B; Zhang S; Zhang Y; Zhu Y
Front Pediatr; 2022; 10():989526. PubMed ID: 36440340
[TBL] [Abstract][Full Text] [Related]
24. The correlation between a Th1/Th2 cytokines imbalance and vitamin D level in patients with early chronic obstructive pulmonary disease (COPD), based on screening results.
Tang W; Rong Y; Zhang H; Zhan Z; Yuan L; Ning Y; Lin W
Front Physiol; 2023; 14():1032786. PubMed ID: 37008007
[No Abstract] [Full Text] [Related]
25. Association Between Vitamin D Levels and FEV1, Number of Exacerbations, and CAT Score in Stable COPD Patients in Indonesia.
Soeroto AY; Setiawan D; Asriputri NN; Darmawan G; Laurus G; Santoso P
Int J Gen Med; 2021; 14():7293-7297. PubMed ID: 34737623
[TBL] [Abstract][Full Text] [Related]
26. Risk factors predict frequent hospitalization in patients with acute exacerbation of COPD.
Wei X; Ma Z; Yu N; Ren J; Jin C; Mi J; Shi M; Tian L; Gao Y; Guo Y
Int J Chron Obstruct Pulmon Dis; 2018; 13():121-129. PubMed ID: 29343951
[TBL] [Abstract][Full Text] [Related]
27. Plasma Cathelicidin is Independently Associated with Reduced Lung Function in COPD: Analysis of the Subpopulations and Intermediate Outcome Measures in COPD Study Cohort.
Burkes RM; Ceppe AS; Couper DJ; Comellas AP; Wells JM; Peters SP; Criner GJ; Kanner RE; Paine R; Christenson SA; Cooper CB; Barjaktarevic IZ; Krishnan JA; Labaki WW; Han MK; Curtis JL; Hansel NN; Wise RA; Drummond MB;
Chronic Obstr Pulm Dis; 2020 Oct; 7(4):370-381. PubMed ID: 33108110
[TBL] [Abstract][Full Text] [Related]
28. Diallyl disulfide inhibits ethanol-induced pulmonary cell vitamin D and antimicrobial peptide cathelicidin depletion.
Ogunsakin O; Sriyotha P; Burns T; Hottor T; McCaskill M
Alcohol; 2019 Nov; 80():99-108. PubMed ID: 30580017
[TBL] [Abstract][Full Text] [Related]
29. [Interleukin-38 expression and clinical significance in serum of patients with chronic obstructive pulmonary disease].
Zhu YQ; Ma SP; Li B; Zheng CY; Ma J
Zhonghua Yi Xue Za Zhi; 2018 Mar; 98(10):759-762. PubMed ID: 29562401
[No Abstract] [Full Text] [Related]
30. Vitamin D deficiency is associated with chronic obstructive pulmonary disease and exacerbation of COPD.
Lokesh KS; Chaya SK; Jayaraj BS; Praveena AS; Krishna M; Madhivanan P; Mahesh PA
Clin Respir J; 2021 Apr; 15(4):389-399. PubMed ID: 33217151
[TBL] [Abstract][Full Text] [Related]
31. Sputum and plasma endothelin-1 levels in exacerbations of chronic obstructive pulmonary disease.
Roland M; Bhowmik A; Sapsford RJ; Seemungal TA; Jeffries DJ; Warner TD; Wedzicha JA
Thorax; 2001 Jan; 56(1):30-5. PubMed ID: 11120901
[TBL] [Abstract][Full Text] [Related]
32. Role of Vitamin D in reducing number of acute exacerbations in Chronic Obstructive Pulmonary Disease (COPD) patients.
Khan DM; Ullah A; Randhawa FA; Iqtadar S; Butt NF; Waheed K
Pak J Med Sci; 2017; 33(3):610-614. PubMed ID: 28811780
[TBL] [Abstract][Full Text] [Related]
33. Impact of exacerbations on respiratory system impedance measured by a forced oscillation technique in COPD: a prospective observational study.
Kamada T; Kaneko M; Tomioka H
Int J Chron Obstruct Pulmon Dis; 2017; 12():509-516. PubMed ID: 28223791
[TBL] [Abstract][Full Text] [Related]
34. Positive correlation between circulating cathelicidin antimicrobial peptide (hCAP18/LL-37) and 25-hydroxyvitamin D levels in healthy adults.
Dixon BM; Barker T; McKinnon T; Cuomo J; Frei B; Borregaard N; Gombart AF
BMC Res Notes; 2012 Oct; 5():575. PubMed ID: 23095332
[TBL] [Abstract][Full Text] [Related]
35. Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels.
Wedzicha JA; Seemungal TA; MacCallum PK; Paul EA; Donaldson GC; Bhowmik A; Jeffries DJ; Meade TW
Thromb Haemost; 2000 Aug; 84(2):210-5. PubMed ID: 10959691
[TBL] [Abstract][Full Text] [Related]
36. [Association of plasma roundabout 4 concentration with pulmonary ventilation function decline in COPD patients].
Jia HZ; Wu YQ; Qin JY; Shen YC; Wen FQ
Zhonghua Yi Xue Za Zhi; 2020 Jan; 100(2):116-120. PubMed ID: 31937050
[No Abstract] [Full Text] [Related]
37. Critical Inhaler Handling Error Is an Independent Risk Factor for Frequent Exacerbations of Chronic Obstructive Pulmonary Disease: Interim Results of a Single Center Prospective Study.
Ahn JH; Chung JH; Shin KC; Choi EY; Jin HJ; Lee MS; Nam MJ; Lee KH
Int J Chron Obstruct Pulmon Dis; 2019; 14():2767-2775. PubMed ID: 31819409
[TBL] [Abstract][Full Text] [Related]
38. Impact of Prolonged Exacerbation Recovery in Chronic Obstructive Pulmonary Disease.
Donaldson GC; Law M; Kowlessar B; Singh R; Brill SE; Allinson JP; Wedzicha JA
Am J Respir Crit Care Med; 2015 Oct; 192(8):943-50. PubMed ID: 26151174
[TBL] [Abstract][Full Text] [Related]
39. Tiotropium and Salmeterol in COPD Patients at Risk of Exacerbations: A Post Hoc Analysis from POET-COPD(®).
Vogelmeier CF; Asijee GM; Kupas K; Beeh KM
Adv Ther; 2015 Jun; 32(6):537-47. PubMed ID: 26100349
[TBL] [Abstract][Full Text] [Related]
40. Plasma 25-hydroxyvitamin D, lung function and risk of chronic obstructive pulmonary disease.
Afzal S; Lange P; Bojesen SE; Freiberg JJ; Nordestgaard BG
Thorax; 2014 Jan; 69(1):24-31. PubMed ID: 23908128
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
